, Biotherapeutics Chemistry, Pfizer Worldwide Research and Development, Cambridge, MA, United States

• MAP Kinase Vol. 4 No. 1 (2015) - Review Articles
  Clinical candidates of small molecule p38 MAPK inhibitors for inflammatory diseases
  Abstract  PDF